Talecris, a developer and manufacturer of immune modulation therapies, has awarded grants to seven researchers as part of its new Talents (Talecris New Trials Support) program.

The grants total nearly $1 million.

Recipients are:

  • Regine Mydlarski, University of Calgary
  • Melvin Berger, Children’s Research Foundation of Cleveland
  • Andreas Goebel, University of Oxford, United Kingdom
  • David Saperstein, Phoenix Neurological Associates in Phoenix
  • Frederick Goldman, University of Iowa, Iowa City, Iowa
  • Mieko Toyoda, Cedars-Sinai Medical Center, Los Angeles
  • Vera Bril, University of Toronto, Canada.